Njideka Okubadejo is an expert in Neurology at Lagos University Teaching Hospital (Nigeria). As of October 2026, ScienceLeadR ranks Njideka Okubadejo in the top 1% of experts in Nigeria for Parkinson Disease and Basal Ganglia Diseases. Njideka Okubadejo has authored 193 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 585 (community average: 125). How the SLR is computed.

LeadR Profile

Njideka Okubadejo Lagos University Teaching Hospital Nigeria
585 ScienceLeadR Reputation 585
Network Map

Neurology

Subspecialties: Genetics - Public Health - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2001 - 2026

Source: PubMed

University of Lagos

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 193

Citations

Citations: 6 073 1st author: 19 Last author: 37 Unique author: 3


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Consistency of Serial Cerebrospinal Fluid α-Synuclein Seed Amplification Assay Results in the Parkinson's Precision Medicine Initiative.
PMID 42865036 — parkinson disease, seeds, movement disorders, precision medicine, synucleins
Mov Disord20260
Implications of the 2025 AHA/ACC hypertension guideline on hypertension prevalence, treatment eligibility and blood pressure control in Nigeria: a cross-sectional comparative study.
PMID 42688995 — hypertension, blood, blood pressure, classification, drug therapy, aged, prevalence, therapeutics
BMJ Public Health20260
Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications.
PMID 42456684 — genes, parkinson disease, genetics, multiple chronic conditions, movement disorders, nervous system
Lancet Neurol Top journal20268
Non-laboratory-based cardiovascular risk assessment:  10-year absolute risk, predicted heart age and intervention requirements in a Nigerian population.
PMID 42432471 — laboratories, risk assessment, heart, cardiovascular diseases, therapeutics
BMC Cardiovasc Disord20260
Repeat expansions in Parkinson's disease and parkinsonism across ancestries: insights from a global genetic cohort.
PMID 42396269 — parkinson disease, parkinsonian disorders, alleles
medRxiv20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 2
Phase 3 1

By status:

Completed 2
Recruiting 1

By type:

Interventional 2
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 10

LeadR Networks

Main global connection map